Galectin Therapeutics annual capital expenditures (capex)
2011
2012
2013
2014
2015
Galectin Therapeutics Capital Expenditures (CapEx) Growth & History (GALT)
Galectin Therapeutics's capital expenditures (capex) was $0 for fiscal 2015.
View full Galectin Therapeutics company overviewGalectin Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2015 | 2015-12-31 | $0 | $0 | — |
| 2014 | 2014-12-31 | $0 | $0 | — |
| 2013 | 2013-12-31 | $0 | −$5,000 | — |
| 2012 | 2012-12-31 | $5,000 | $0 | 0.00% |
| 2011 | 2011-12-31 | $5,000 | — | — |
Galectin Therapeutics capital expenditures (capex) trends
Between the periods ended 2011-12-31 and 2015-12-31, Galectin Therapeutics's capital expenditures (capex) decreased from $5,000 to $0, a change of −$5,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Galectin Therapeutics source filings ↗